Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Passaro

Showing results (911-920 of 950) with videos related to

Pageof 95
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2024
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSAE Felip, B C Cho, V Gutiérrez, et al.
Human Vaccines & Immunotherapeutics|March 8, 2014
Influenza vaccination coverage among medical residents: an Italian multicenter surveyClaudio Costantino, Walter Mazzucco, Elena Azzolini, et al.
The New England Journal of Medicine|September 9, 2025
Overall Survival with Amivantamab-Lazertinib in <i>EGFR</i>-Mutated Advanced NSCLCJames Chih-Hsin Yang, Shun Lu, Hidetoshi Hayashi, et al.
The New England Journal of Medicine|June 26, 2024
Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i>-Mutated Advanced NSCLCByoung C Cho, Shun Lu, Enriqueta Felip, et al.
ESMO Open|January 24, 2026
Global advances and future directions in lung cancer care: expert consensus and strategic prioritiesM-L Meyer, S Peters, P A Jänne, et al.
Translational Lung Cancer Research|September 11, 2023
International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary diseaseChengzhi Zhou, Yinyin Qin, Wei Zhao, et al.
Physical Review Letters|August 23, 2021
Odderon Exchange from Elastic Scattering Differences between pp and pp[over ¯] Data at 1.96 TeV and from pp Forward Scattering MeasurementsV M Abazov, B Abbott, B S Acharya, et al.
Physical Review Letters|March 22, 2024
Fraction of χ_{c} Decays in Prompt J/ψ Production Measured in pPb Collisions at sqrt[s_{NN}]=8.16  TeVR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Physical Review Letters|February 16, 2024
Improved Measurement of CP Violation Parameters in B_{s}^{0}→J/ψK^{+}K^{-} Decays in the Vicinity of the ϕ(1020) ResonanceR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Physical Review Letters|July 1, 2024
Modification of χ_{c1}(3872) and ψ(2S) Production in pPb Collisions at sqrt[s_{NN}]=8.16  TeVR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Pageof 95

Showing results (911-920 of 950) with videos related to

Sort By:
Pageof 95
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2024
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSAE Felip, B C Cho, V Gutiérrez, et al.
Human Vaccines & Immunotherapeutics|March 8, 2014
Influenza vaccination coverage among medical residents: an Italian multicenter surveyClaudio Costantino, Walter Mazzucco, Elena Azzolini, et al.
The New England Journal of Medicine|September 9, 2025
Overall Survival with Amivantamab-Lazertinib in <i>EGFR</i>-Mutated Advanced NSCLCJames Chih-Hsin Yang, Shun Lu, Hidetoshi Hayashi, et al.
The New England Journal of Medicine|June 26, 2024
Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i>-Mutated Advanced NSCLCByoung C Cho, Shun Lu, Enriqueta Felip, et al.
ESMO Open|January 24, 2026
Global advances and future directions in lung cancer care: expert consensus and strategic prioritiesM-L Meyer, S Peters, P A Jänne, et al.
Translational Lung Cancer Research|September 11, 2023
International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary diseaseChengzhi Zhou, Yinyin Qin, Wei Zhao, et al.
Physical Review Letters|August 23, 2021
Odderon Exchange from Elastic Scattering Differences between pp and pp[over ¯] Data at 1.96 TeV and from pp Forward Scattering MeasurementsV M Abazov, B Abbott, B S Acharya, et al.
Physical Review Letters|March 22, 2024
Fraction of χ_{c} Decays in Prompt J/ψ Production Measured in pPb Collisions at sqrt[s_{NN}]=8.16  TeVR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Physical Review Letters|February 16, 2024
Improved Measurement of CP Violation Parameters in B_{s}^{0}→J/ψK^{+}K^{-} Decays in the Vicinity of the ϕ(1020) ResonanceR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Physical Review Letters|July 1, 2024
Modification of χ_{c1}(3872) and ψ(2S) Production in pPb Collisions at sqrt[s_{NN}]=8.16  TeVR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Pageof 95